First Trust NYSE Arca Biotechnology Index Fund
FBT
256 hedge funds and large institutions have $1.1B invested in First Trust NYSE Arca Biotechnology Index Fund in 2024 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 83 increasing their positions, 79 reducing their positions, and 30 closing their positions.
91% more capital invested
Capital invested by funds: $576M → $1.1B (+$526M)
13% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 30
5% more repeat investments, than reductions
Existing positions increased: 83 | Existing positions reduced: 79
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% less funds holding
Funds holding: 257 → 256 (-1)
0.55% less ownership
Funds ownership: 51.95% → 51.4% (-0.55%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LJAC
L.J. Altfest & Co
New York
|
+$5.16M |
| 2 |
MWM
Modern Wealth Management
Lenexa,
Kansas
|
+$5.09M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$5.02M |
| 4 |
Jane Street
New York
|
+$3.34M |
| 5 |
Goldman Sachs
New York
|
+$2.58M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
-$3.94M |
| 2 |
GWA
GGM Wealth Advisors
Baltimore,
Maryland
|
-$3.59M |
| 3 |
NA
Navellier & Associates
Reno,
Nevada
|
-$2.95M |
| 4 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
-$2.6M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$2.27M |
FBT Hedge Fund Activity: Q4 2024 in Review
256 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q4 2024, worth a combined $1.1B — up 91% from $576M a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new FBT positions and 30 closed out — a net gain of 4 holders — while 83 added to existing stakes and 79 trimmed.
The largest buyer was L.J. Altfest & Co, opening a new position worth an estimated $5.16M. The largest seller was D.A. Davidson & Co, cutting an estimated $3.94M.
- 256 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q4 2024, down from 257 in Q3 2024.
- Funds reported $1.1B of First Trust NYSE Arca Biotechnology Index Fund stock for Q4 2024, up 91% quarter-over-quarter.
- 34 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q4 2024 and 30 closed out, a net change of +4 holders.
- The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q4 2024 was L.J. Altfest & Co, an estimated $5.16M added.
- The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q4 2024 was D.A. Davidson & Co, an estimated $3.94M sold.
Based on aggregated 13F filings for Q4 2024.